Carotid Disease
NYU remains a leader in both the screening for carotid disease using ultrasound technologies and the prevention of stroke by the treatment of carotid disease. Stroke is often a preventable disease. Carotid artery occlusive disease is known to predispose patients to stroke. After Dr. Imparato helped to pioneer carotid endarterectomy as an open surgical procedure, NYU has remained extremely active in the academic output surrounding carotid artery disease. In addition, the Division has remained on the cutting edge of almost all clinical trials in carotid artery disease. The Division has established itself as a central figure in the education of students, residents, fellows, and other vascular surgeons by its extensive publications of general articles, book chapters, and national presentations.
The most potent area for clinical research and carotid disease is now cerebral protection. While stenting of the carotid artery may ultimately be the mainstay of carotid artery therapy, the pitfall of this technology remains the possibility that carotid plaque may break loose, and deposit itself in the brain, causing stroke. Here, a series of devices have been developed to help prevent these atheroembolic complications. NYU remains critically involved in the development and trial of these devices.
To learn more about Carotid Artery Disease, click here.
To learn more about Carotid Artery Disease tests, click:
To learn more about Carotid Artery Disease treatments, click:
To learn more about Carotid Artery Disease risk factor management, click:
Click here to view our videos regarding Carotid Artery Disease.
